Rankings
▼
Calendar
TSHA Q2 2020 Earnings — Taysha Gene Therapies, Inc. Revenue & Financial Results | Market Cap Arena
TSHA
Taysha Gene Therapies, Inc.
$1B
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$21M
EPS (Diluted)
$-0.61
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$11M
Total Liabilities
$20M
Stockholders' Equity
-$9M
Cash & Equivalents
$11M
← FY 2020
All Quarters
Q3 2020 →
